London · Delayed Price · Currency is GBP · Price in GBX Oxford Biomedica Statistics
Total Valuation
LON:OXB has a market cap or net worth of GBP 593.09 million. The enterprise value is 676.45 million.
| Market Cap | 593.09M |
| Enterprise Value | 676.45M |
Important Dates
The last earnings date was Tuesday, September 22, 2026.
| Earnings Date | Sep 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LON:OXB has 121.04 million shares outstanding. The number of shares has increased by 15.26% in one year.
| Current Share Class | 121.04M |
| Shares Outstanding | 121.04M |
| Shares Change (YoY) | +15.26% |
| Shares Change (QoQ) | +3.22% |
| Owned by Insiders (%) | 1.84% |
| Owned by Institutions (%) | 41.33% |
| Float | 60.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.38 |
| PB Ratio | 10.21 |
| P/TBV Ratio | 17.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.21, with a Debt / Equity ratio of 2.73.
| Current Ratio | 2.21 |
| Quick Ratio | 1.76 |
| Debt / Equity | 2.73 |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.17 |
| Interest Coverage | -1.93 |
Financial Efficiency
Return on equity (ROE) is -89.69% and return on invested capital (ROIC) is -20.48%.
| Return on Equity (ROE) | -89.69% |
| Return on Assets (ROA) | -7.03% |
| Return on Invested Capital (ROIC) | -20.48% |
| Return on Capital Employed (ROCE) | -13.00% |
| Weighted Average Cost of Capital (WACC) | 9.67% |
| Revenue Per Employee | 172,432 |
| Profits Per Employee | -40,048 |
| Employee Count | 977 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 5.32 |
Taxes
| Income Tax | -1.39M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.03% in the last 52 weeks. The beta is 1.09, so LON:OXB's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -15.03% |
| 50-Day Moving Average | 508.88 |
| 200-Day Moving Average | 623.78 |
| Relative Strength Index (RSI) | 54.33 |
| Average Volume (20 Days) | 871,709 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:OXB had revenue of GBP 175.36 million and -40.73 million in losses. Loss per share was -0.34.
| Revenue | 175.36M |
| Gross Profit | 63.46M |
| Operating Income | -28.97M |
| Pretax Income | -42.12M |
| Net Income | -40.73M |
| EBITDA | -22.72M |
| EBIT | -28.97M |
| Loss Per Share | -0.34 |
Balance Sheet
The company has 75.28 million in cash and 158.64 million in debt, with a net cash position of -83.36 million or -0.69 per share.
| Cash & Cash Equivalents | 75.28M |
| Total Debt | 158.64M |
| Net Cash | -83.36M |
| Net Cash Per Share | -0.69 |
| Equity (Book Value) | 58.10M |
| Book Value Per Share | 0.48 |
| Working Capital | 92.26M |
Cash Flow
In the last 12 months, operating cash flow was -20.56 million and capital expenditures -10.15 million, giving a free cash flow of -30.71 million.
| Operating Cash Flow | -20.56M |
| Capital Expenditures | -10.15M |
| Depreciation & Amortization | 6.24M |
| Net Borrowing | 7.64M |
| Free Cash Flow | -30.71M |
| FCF Per Share | -0.25 |
Margins
Gross margin is 36.19%, with operating and profit margins of -16.52% and -23.23%.
| Gross Margin | 36.19% |
| Operating Margin | -16.52% |
| Pretax Margin | -24.02% |
| Profit Margin | -23.23% |
| EBITDA Margin | -12.96% |
| EBIT Margin | -16.52% |
| FCF Margin | n/a |
Dividends & Yields
LON:OXB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -15.26% |
| Shareholder Yield | -15.26% |
| Earnings Yield | -6.87% |
| FCF Yield | -5.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for LON:OXB is 703.50, which is 40.42% higher than the current price. The consensus rating is "Buy".
| Price Target | 703.50 |
| Price Target Difference | 40.42% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 18.35% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on May 30, 2018. It was a reverse split with a ratio of 0.02.
| Last Split Date | May 30, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.02 |
Scores
LON:OXB has an Altman Z-Score of 0.31 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.31 |
| Piotroski F-Score | 3 |